• Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$34.78
▼ -0.1 (-0.29%)
Get New HCP Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for HCP and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for HCP

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for HCP in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $34.78.

This chart shows the closing price for HCP for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is N/A

The current consensus among 0 investment analysts is to n/a stock in HCP. This rating has held steady since September 2020, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 7 buy ratings
  • 1 hold ratings
  • 0 sell ratings
5/1/2020
  • 0 strong buy ratings
  • 6 buy ratings
  • 1 hold ratings
  • 0 sell ratings
7/30/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/28/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/26/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/26/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/25/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/23/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/23/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
10/8/2019JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$35.00 ➝ $38.00Low
10/2/2019BarclaysBoost Price TargetOverweight$37.00 ➝ $39.00Low
10/2/2019KeyCorpBoost Price TargetOverweight$34.00 ➝ $37.00Low
9/30/2019ScotiabankSet Price TargetBuy$38.00Medium
9/17/2019Morgan StanleyBoost Price TargetEqual Weight$32.00 ➝ $35.00High
9/10/2019JPMorgan Chase & Co.Boost Price TargetNeutral$32.00 ➝ $35.00High
9/10/2019ArgusUpgradeHold ➝ BuyHigh
9/3/2019BarclaysInitiated CoverageOverweight$37.00High
9/3/2019Stifel NicolausBoost Price TargetBuy$34.00 ➝ $37.00High
8/1/2019Stifel NicolausBoost Price TargetBuy$32.00 ➝ $34.00Medium
7/1/2019KeyCorpBoost Price TargetOverweight$32.00 ➝ $34.00Medium
6/13/2019Raymond JamesUpgradeMarket Perform ➝ Outperform$35.00Medium
3/28/2019Morgan StanleySet Price TargetHold$32.00Medium
2/13/2019BMO Capital MarketsReiterated RatingBuy$33.00Low
1/9/2019BMO Capital MarketsUpgradeMarket Perform ➝ Outperform$30.00 ➝ $33.00Low
1/7/2019Robert W. BairdUpgradeNeutral ➝ OutperformMedium
12/10/2018ScotiabankInitiated CoverageOutperform$32.00Medium
11/2/2018Royal Bank of CanadaUpgradeSector Perform ➝ OutperformMedium
11/1/2018Cantor FitzgeraldBoost Price TargetOverweight ➝ Overweight$29.00 ➝ $30.00Medium
10/31/2018BMO Capital MarketsReiterated RatingHold$27.00High
10/5/2018JPMorgan Chase & Co.DowngradeOverweight ➝ NeutralLow
9/27/2018Cantor FitzgeraldUpgradeNeutral ➝ Overweight$28.00 ➝ $29.00High
9/17/2018Bank of AmericaBoost Price TargetBuy$27.50 ➝ $28.00Medium
8/16/2018Morgan StanleyBoost Price TargetEqual Weight ➝ Equal Weight$23.50 ➝ $25.00Low
8/13/2018MizuhoReiterated RatingBuy$29.00Low
8/9/2018Robert W. BairdBoost Price TargetNeutral ➝ Neutral$24.00 ➝ $26.00Low
8/7/2018Cantor FitzgeraldInitiated CoverageNeutral$28.00Low
8/3/2018Stifel NicolausSet Price TargetBuy ➝ Buy$27.00 ➝ $28.00Low
7/24/2018Capital One FinancialInitiated CoverageEqual Weight$27.50Low
7/23/2018Capital One FinancialReiterated RatingEqual WeightLow
6/14/2018Morgan StanleyLower Price TargetEqual Weight ➝ Equal Weight$28.00 ➝ $23.50Low
6/1/2018Raymond JamesReiterated RatingMarket PerformLow
6/1/2018Evercore ISIDowngradeIn-Line ➝ UnderperformLow
5/21/2018Evercore ISIDowngradeIn-Line ➝ Underperform$23.02 ➝ $24.00Low
5/21/2018Raymond JamesDowngradeOutperform ➝ Market PerformLow
5/3/2018BMO Capital MarketsReiterated RatingHold$25.00Low
3/20/2018Wells Fargo & CompanyLower Price TargetMarket Perform ➝ Market Perform$31.00 ➝ $27.00Low
3/8/2018Bank of AmericaUpgradeNeutral ➝ Buy$22.63 ➝ $25.00Low
2/23/2018Royal Bank of CanadaReiterated RatingHold$27.00Low
2/21/2018UBS GroupReiterated RatingSell ➝ Sell$25.00 ➝ $21.00Medium
2/15/2018Robert W. BairdSet Price TargetHold$24.00Low
2/15/2018MizuhoSet Price TargetBuy$26.00Low
2/14/2018Stifel NicolausReiterated RatingBuy ➝ Buy$29.00 ➝ $27.00High
2/13/2018Jefferies Financial GroupReiterated RatingHold$26.00Medium
2/13/2018BMO Capital MarketsSet Price TargetHold$25.00Medium
1/15/2018BMO Capital MarketsSet Price TargetHold$25.00Low
1/5/2018Robert W. BairdLower Price TargetNeutral ➝ Neutral$29.00 ➝ $26.00Medium
12/15/2017JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$29.00Medium
12/14/2017Morgan StanleyReiterated RatingEqual Weight$29.00Low
12/5/2017Stifel NicolausUpgradeHold ➝ Buy$29.00Low
11/7/2017Stifel NicolausLower Price TargetHold ➝ Hold$30.00 ➝ $29.00N/A
11/2/2017MizuhoUpgradeNeutral ➝ Buy$32.00N/A
10/18/2017BMO Capital MarketsReiterated RatingHold$28.00N/A
10/17/2017KeyCorpReiterated RatingHoldN/A
10/4/2017Stifel NicolausReiterated RatingHold$30.00Low
10/2/2017UBS GroupDowngradeNeutral ➝ Sell$30.00 ➝ $25.00High
9/25/2017Morgan StanleyLower Price TargetEqual Weight$31.00 ➝ $29.00Low
9/22/2017Bank of AmericaDowngradeBuy ➝ Neutral$33.00 ➝ $31.00High
9/17/2017KeyCorpReiterated RatingHoldLow
9/6/2017BMO Capital MarketsReiterated RatingHold$32.00Low
8/22/2017Stifel NicolausReiterated RatingHold$30.00Medium
7/25/2017Jefferies Financial GroupReiterated RatingHold$33.00Low
7/24/2017The Goldman Sachs GroupDowngradeBuy ➝ Neutral$35.00 ➝ $32.00Medium
7/14/2017Stifel NicolausReiterated RatingHold$31.00Medium
7/5/2017Royal Bank of CanadaReiterated RatingHold$31.00High
6/28/2017MizuhoReiterated RatingNeutralLow
6/14/2017Raymond JamesUpgradeUnderperform ➝ Outperform$35.00Low
6/14/2017UBS GroupUpgradeUnderperform ➝ OutperformN/A
5/12/2017Jefferies Financial GroupReiterated RatingHold$32.00High
4/24/2017Evercore ISIDowngradeIn-Line ➝ UnderperformMedium
4/21/2017Mitsubishi UFJ Financial GroupInitiated CoverageHold$32.00Low
4/11/2017MizuhoDowngradeBuy ➝ Neutral$34.00 ➝ $32.00Low
4/3/2017Bank of AmericaUpgradeNeutral ➝ Buy$33.25 ➝ $35.00Low
3/27/2017Evercore ISIUpgradeUnderperform ➝ In-LineLow
3/20/2017Morgan StanleyUpgradeUnderweight ➝ Equal Weight$31.00Low
3/10/2017Robert W. BairdInitiated CoverageNeutral ➝ Neutral$32.00Low
3/3/2017Evercore ISIDowngradeHold ➝ UnderperformN/A
2/14/2017BMO Capital MarketsReiterated RatingHold$30.00N/A
2/14/2017BarclaysBoost Price TargetEqual Weight$32.00 ➝ $33.00N/A
1/25/2017The Goldman Sachs GroupUpgradeNeutral ➝ Buy$29.00 ➝ $35.00N/A
1/5/2017BarclaysReiterated RatingEqual Weight$32.00N/A
1/3/2017Royal Bank of CanadaSet Price TargetHold$30.00N/A
12/23/2016MizuhoReiterated RatingBuyN/A
12/13/2016BMO Capital MarketsUpgradeUnderperform ➝ Market Perform$29.00 ➝ $30.00N/A
11/21/2016MizuhoUpgradeNeutral ➝ Buy$31.00 ➝ $32.00N/A
11/4/2016Royal Bank of CanadaUpgradeUnderperform ➝ Sector Perform$35.00 ➝ $30.00N/A
11/2/2016Stifel NicolausUpgradeSell ➝ Hold$33.00 ➝ $31.00N/A
11/2/2016MizuhoLower Price TargetNeutral$37.00 ➝ $31.00N/A
11/1/2016BTIG ResearchReiterated RatingNeutralN/A
11/1/2016BMO Capital MarketsReiterated RatingSell$33.00N/A
(Data available from 10/23/2016 forward)

News Sentiment Rating

0.64 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/27/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/26/2021
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/26/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/25/2021
  • 1 very positive mentions
  • 2 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
7/25/2021
  • 1 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/24/2021
  • 3 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/23/2021
  • 3 very positive mentions
  • 5 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
10/23/2021

Current Sentiment

  • 3 very positive mentions
  • 5 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
HCP logo
HCP, Inc. is a fully integrated real estate investment trust (REIT) that invests in real estate serving the healthcare industry in the United States. HCP owns a large-scale portfolio primarily diversified across life science, medical office and senior housing. Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index.
Read More

Today's Range

Now: $34.78
Low: $34.63
High: $34.97

50 Day Range

MA: $30.54
Low: $28.42
High: $35.78

52 Week Range

Now: $34.78
Low: $26.58
High: $37.93

Volume

1,750,341 shs

Average Volume

3,008,769 shs

Market Capitalization

$17.08 billion

P/E Ratio

19.11

Dividend Yield

4.14%

Beta

0.22

Frequently Asked Questions

What sell-side analysts currently cover shares of HCP?

The following sell-side analysts have issued stock ratings on HCP in the last year:
View the latest analyst ratings for HCP.

What is the current price target for HCP?

0 Wall Street analysts have set twelve-month price targets for HCP in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for HCP in the next year.
View the latest price targets for HCP.

What is the current consensus analyst rating for HCP?

HCP currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for HCP.

How do I contact HCP's investor relations team?

HCP's physical mailing address is 1920 MAIN STREET SUITE 1200, IRVINE CA, 92614. The real estate investment trust's listed phone number is 949-407-0700 and its investor relations email address is [email protected] The official website for HCP is www.hcpi.com.